Press Releases

Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jan 06, 2020
Alector Initiates First-in-Human Dosing in Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
Jan 06, 2020
PDF Version
Displaying 11 - 12 of 12

Contact us

Alector, Inc.
131 Oyster Point Blvd, Suite 600
South San Francisco, CA 94080

Get in touch

Copyright Alector, Inc. 2020.   Privacy Policy   Do Not Sell My Information   Site by Barrel